Marco Moschini

42PUBLICATIONS
161CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer diagnosisMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Mar 20, 2026
Refining BCG-failure classifications in non-muscle-invasive bladder cancer.

Aleksander Ślusarczyk, Pietro Scilipoti, Roberto Contieri

|Mar 03, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.

Ana Fernández-Mardomingo, Jose Daniel Subiela, Alberto Artiles Medina

|Aug 29, 2025
Defining statistical cure in patients with T1 high-grade non-muscle-invasive bladder carcinoma treated with BCG immunotherapy.

José Daniel Subiela, Irene de la Parra, Javier Taborda

|Jul 29, 2025
Response to Hof et al.: spurious associations between BCG instillations and outcomes in non-muscle-invasive bladder cancer.

Mattia Longoni, Pietro Scilipoti, Paolo Zaurito

|Jul 09, 2025
Impact of timing of computed tomography staging and patient factors on the detection of 'true' cN+ bladder cancer.

Markus von Deimling, Marc Furrer, Alberto Bianchi

|Jun 20, 2025
Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer.

Valentina Tateo, Joep J de Jong, Antonio Cigliola

Pageof 7

Frequent Collaborators

17 joint publications

Ekaterina Laukhtina

15 joint publications

Francesco Soria

11 joint publications

Simone Albisinni

11 joint publications

Keiichiro Mori